Delta creatine kinase–MB outperforms myoglobin at two hours during the emergency department identification and exclusion of troponin positive non–ST-segment elevation acute coronary syndromes☆☆☆★★★
To access this article, please choose from the options below
☆ Author contributions: FMF conceived the study and obtained research funding. All authors were involved in conception and design of the study. FMF and RHC were responsible for analysis and interpretation of data. FMF drafted the manuscript, and all authors contributed substantially to its revision. FMF takes responsibility for the paper as a whole.
☆☆ Presented at the American College of Emergency Physicians Research Forum, Seattle, WA, October 15, 2002.
★ Supported by unrestricted research grants from Phillips Medical Systems (formerly Hewlett-Packard), Millennium Pharmaceuticals Inc. (formerly Cor Therapeutics), Bristol-Myers Squibb Medical Imaging (formerly DuPont RadioPharmaceuticals), and EmCare, Inc.
★★ Reprints not available from the authors.
PII: S0196-0644(04)00094-0
doi:10.1016/j.annemergmed.2004.02.003
© 2004 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.
